United States transcatheter heart valve device market

The US heart valve device market has seen rapid shifts in market dynamics, from renewed growth in the surgical heart valve device segment to the introduction of novel products and key approvals of existing products for new indications. In particular, recent approvals of transcatheter tricuspid therapies will support growth in coming years. The market continues to grow more competitive as more players enter the space and engage in mergers and acquisitions.
Read more to get a Market Snapshot of the state of the market for heart valve devices in the US from 2019 through 2033.
